MedPath

Prognosis and Survival Estimates in Palliative Therapy

Completed
Conditions
Cancer
Interventions
Other: no specific interventions
Registration Number
NCT00871520
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

The accuracy of clinical survival estimates is tested in comparison to objective prognostic scores.

Detailed Description

* At presentation a clinical survival estimate is obtained in each patient.

* Survival is also estimated using published prognostic scores in palliative care.

* Prognostic scores based on blood samples, general symptoms, complaints, and performance status are calculated and validated, respectively

* Each patient completes questionnaires on psychological distress

* Survival estimates are limited to 6 months.

* Each patient is followed for at least 6 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
612
Inclusion Criteria
  • oncologic disease confirmed
  • incurable locally advanced or metastatic disease
  • palliative treatment intended
  • age > 18
  • able to understand the study protocol
  • able to complete the forms with assistance if necessary
Exclusion Criteria
  • therapy with curative intent
  • regular clinical follow-up visit without disease progression
  • ongoing therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Palliative Therapyno specific interventionsPatients referred to the oncology / radiation oncology departments for palliative therapy.
Primary Outcome Measures
NameTimeMethod
Survival6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Sana Kliniken Duesseldorf Gerresheim, MVZ Onkologie

🇩🇪

Duesseldorf, NRW, Germany

University Hospital Duesseldorf, Radiation Oncology Dept.

🇩🇪

Duesseldorf, NRW, Germany

Sana Kliniken Duesseldorf Benrath

🇩🇪

Duesseldorf, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath